Who we are
One of Japan’s leading independent strategic communication consultancies providing a full range of services from planning to execution.
An industry pioneer, we have been at the heart of establishing strategic public relations in Japan.
Today we specialize in communication activities for companies and organizations in the healthcare sector.
Our Experience
COSMO has partnered with more than 500 companies, international and domestic, to develop localized communication strategies tailored for the Japanese market.
Our People
COSMO's staff come from diverse professional backgrounds and are multi-cultural and bilingual. This allows us to assign Japanese and international professionals for the unique requirements of each project.
Our Expertise
Our seasoned advisors and communication consultants work together with a wide network of key opinion leaders to craft and execute award-winning communication strategies.
News
Survey Results: Exploring Strategies for Media and Healthcare Companies in a Post-COVID Era
Online interviews now a well-established practice with 90% of respondents eager to continue, but face-to-face reporting still holds value In May 2023, COVID-19 was reclassified as a Class 5 infectious disease under the Infectious Disease Control Law, marking a significant milestone in the post-COVID era. As the pandemic subsides, our daily lives and business activities are gradually returning to normal. In light of these changes, COSMO PR conducted a second media survey in August 2024, following up on the first
Healthcare and The Environment: Environmental Changes and Health in Medical Practice What changes should we expect from work style reforms for doctors?
Since 2019, different industries across Japan have begun implementing upper limit regulations on overtime and holiday working hours under the “Work Style Reform Act.” A five-year grace period was given to the medical industry, with the Revised Medical Law enacted in 2021. After three years of preparation, overtime and holiday working for doctors will be limited from April 1 this year to no more than 960 hours a year, with some exceptions depending on the type of medical institution. What
The Year in Review & Optimism for 2024
Dear Friends and Colleagues, First and foremost, I would like to take this opportunity to thank you for your continued support.
Health Care and The Environment: The Risks Posed by Climate Change How should the healthcare industry respond?
Health issues caused by the rising temperatures associated with climate change have increased dramatically in recent years. Record heat waves in Europe caused more than 60,000 deaths last year, while a sharp increase in climate disasters such as floods and droughts in Africa have led to worsening food security and the spread of infectious diseases. Japan is no exception, and the number of “Heat Stroke Alerts” issued by the Ministry of the Environment continues to rise each year. This year,
Healthcare and The Environment: Environmental Changes and Health in Medical Practice What changes should we expect from work style reforms for doctors?
Since 2019, different industries across Japan have begun implementing upper limit regulations on overtime and holiday working hours under the “Work Style Reform Act.” A five-year grace period was given to the medical industry, with the Revised Medical Law enacted in 2021. After three years of preparation, overtime and holiday working for doctors will be limited from April 1 this year to no more than 960 hours a year, with some exceptions depending on the type of medical institution. What
Health Care and The Environment: The Risks Posed by Climate Change How should the healthcare industry respond?
Health issues caused by the rising temperatures associated with climate change have increased dramatically in recent years. Record heat waves in Europe caused more than 60,000 deaths last year, while a sharp increase in climate disasters such as floods and droughts in Africa have led to worsening food security and the spread of infectious diseases. Japan is no exception, and the number of “Heat Stroke Alerts” issued by the Ministry of the Environment continues to rise each year. This year,
Healthcare and the Environment: Understanding the Movement around PFASHow should the healthcare industry face this issue?
Have you heard of PFAS? Standing for “Per- and Polyfluorinated Substances,” PFAS is the generic name for artificially created organic fluorine compounds. Capable of repelling water and oil, in addition to being highly resistant to heat, chemicals, and ultraviolet rays, they are used in a wide range of applications from water repellents and emulsifiers, to fire extinguishing agents and surface treatments for packaging materials. However, as stable compounds, PFAS have also become known as “forever chemicals” since they can remain
Solving Challenges Around Rare and Intractable Diseases Through Stakeholder Collaboration
Moving toward an era when patients, healthcare professionals, and pharmaceutical companies take action together
The Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Pharmaceuticals and Medical Devices Act) defines “Rare Disease” as that with fewer than 50,000 patients in Japan. In recent years we have seen a rise in activities being held in Japan and around the world to raise awareness of rare and intractable diseases. These are largely driven by patient groups, but pharmaceutical companies are also starting to more actively provide information and develop new drugs.
Survey Results: Exploring Strategies for Media and Healthcare Companies in a Post-COVID Era
Online interviews now a well-established practice with 90% of respondents eager to continue, but face-to-face reporting still holds value In May 2023, COVID-19 was reclassified as a Class 5 infectious disease under the Infectious Disease Control Law, marking a significant milestone in the post-COVID era. As the pandemic subsides, our daily lives and business activities are gradually returning to normal. In light of these changes, COSMO PR conducted a second media survey in August 2024, following up on the first
Online Seminar Report by COSMO Public Relations
The Impact of COVID-19 on American Life -Through the Lens of a Leading Global Health Expert- The COVID-19 pandemic has undoubtedly had a major impact on the daily lives of people around the world. At the COSMO Online Seminar held on November 5, Dr. Dairiku Hozumi, Managing Director of ThinkWell Global, a U.S. think tank specializing in healthcare financing, and Independent Director at COSMO Public Relations Corporation (“COSMO”), was invited to share his thoughts on the current situation in
Online Seminar Co-sponsored by Welby and COSMO Public Relations
The impact of ePRO on patients’ cancer treatment experience -Benefits and issues of ePRO as observed in real-word clinical settings- Cosmo Public Relations (“COSMO”) and Welby, Inc. co-sponsored an online seminar on May 21, 2021 titled: “The impact of ePRO on patients’ cancer treatment experience: the benefits and issues of ePRO as observed in real-world clinical settings.” The event brought together professionals committed to exploring the use of new digital solutions to improve the treatment experience of patients with
Online Seminar Co-sponsored by Insights4 Pharma and Cosmo Public Relations
Aligning pharma business objectives with patients’ life goals -Applying the patient insight approach of drug development to communications- Healthcare in Japan is undergoing drastic change. To address these shifting trends, COSMO co-hosted an online seminar with global pharmaceutical news media Insights4 Pharma. The seminar succeeded in spotlighting the crucial role of patient insights, particularly: • The pursuit of patient insights leads to early detection of disease, prevention of serious illness, improved adherence, and improved healthcare outcomes. • A solid understanding of
COSMO Healthcare Interview: “Japan in 10 Minutes”
No. 2: Dr. Masaharu Tsubokura, MD, of Hirata Central Hospital in Fukushima As the second segment of COSMO’s “Japan in 10 Minutes” interview series, our CEO Kumi Sato interviews with Dr. Tsubokura, of Hirata Central Hospital in Japan. In the interview, Dr. Tsubokura discussed the situation about PCR testing and Antibody testing in Japan.
COSMO Healthcare YouTube Channel Opened
～ 1st Video “COSMO Healthcare Special Interview –Japan in 10 Minutes” COSMO Healthcare has now opened a YouTube channel to disseminate medical information and news of industry trends.
Careers
Interested in working with us?
Since its founding in 1960, COSMO has been a pioneering force behind countless transformations in Japan’s public relations industry. To this day, each of us carry this trailblazer spirit as a company of leaders, and never followers.
Contact & Access
7F Azabu Kaisei Building,
1-8-10 Azabudai
Minato-ku, Tokyo,
Japan 〒106-0041
TEL +81(0)3-5561-2911 ｜
FAX +81(0)3-5561-2912